Loading...

Price Table

* Prices are based on daily market changes.
DateOpenHighLowCloseVolumeDelivery %20-Day sma50-Day sma200-Day sma
Loading...

Day High Low Range

TimeLowestHighestVolume
Loading...

Past Performance & Moving Averages

Day’sLow high rangeSMAStock performanceNifty performance
Loading...

PIVOT POINTS

NAMES4S3S2S1PIVOT POINTSR1R2R3R4
CLASSIC---------
WOODIE‘S----
FIBONACCI--
CAMARILLA-
Loading...

Trend Analysis

Loading...

Key Data

Market capBook valuestock p/eDividend yieldroceroesales growth (3Y)face value (3Y)

Profile

ERIS It was incorporated as “Eris Lifescience Private Limited” as on January 25, 2007, as a private limited company under the Companies Act 1956, at Ahmedabad, along with a certificate of incorporation granted by the Registrar of Companies, Gujarat, Dadra, and Nagar Haveli. According to a resolution of the Shareholders dated February 5, 2007, the company name was changed to “Eris Lifesciences Private Limited” and a fresh certificate of incorporation was being issued by the Registrar of Companies, Gujarat, Dadra, and Nagar Haveli as on February 9, 2007. Further, according to a conversion of the company to a public limited company, and as approved by the Shareholders via a resolution dated January 31, 2017, the company name was changed to “Eris Lifesciences Limited,” and the RoC also issued a fresh certificate of incorporation as on February 2, 2017.

Some of the Milestones:

  • 2007:
  • The incorporation of the company took place.
  • It launched the “Eris” division focused on the cardiology and diabetes segment.
  • 2008: It launched “Nikkos” division focused on gastroenterology and orthopedics segment.
  • 2009: It launched the “Adura” division focused on the cardiology and diabetes segment.
  • 2011: It launched the “Montana” division focused on the gynecology and pediatrics segment.
  • 2012: It launched the “Inspira” division focused on the cardiology segment.
  • 2014:
  • It launched the “Victus” division focused on the anti-diabetes segment.
  • It also set up the Assam Facility by the Company.
  • 2015: It launched the “Eris 2” division focused on the pain management segment.
  • 2016:
  • It acquired 40 registered and unregistered trademarks from Amay Pharmaceuticals Private Limited (now, Aprica Pharmaceuticals Private Limited).
  • It acquired 100.00% of the outstanding equity shares of Aprica Healthcare Private Limited.
  • It acquired 75.48% of the outstanding equity shares of Kinedex Healthcare Private Limited.
  • 2017: It acquired the trademarks ‘UNION’, ‘REUNION’ and ‘BON UNION.’

Some of the Achievements:

  • 2013:
  • Frost & Sullivan awarded it the ‘Competitive Strategy Leadership’ award.
  • It was awarded the ‘Emerging Companies Excellence’ award for scalability of the business model and managing operational efficiencies by Business Today and Yes Bank.
Get the Latest IPO updates at NiftyTrader Money